 |
|
January 7, 2026 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
 |
- Anavex Life Sciences: Receives FDA Feedback
on Alzheimer’s Disease Program More
- Compass Pathways: FDA Acceptance of IND
Application for PTSD and Hosts Webinar on PTSD
and TRD More
- Cytora Therapeutics, Made Scientific, and
Zeo ScientifiX: Partnership to Manufacture and
Commercialize Cytora's Allogeneic Stem Cell
Therapy in the United States More
- EA Pharma: Initiation of its Phase III
Clinical Trial With Evenamide, a Novel
Treatment for Schizophrenia, in Japan More
- Gilgamesh Pharma: Positive Topline Phase 2a
Results for Blixeprodil (GM-1020) in Major
Depressive Disorder More
- HUTCHMED: Positive Topline Results
of Phase III Part of ESLIM-02 Trial of
Sovleplenib for Warm Antibody Autoimmune
Hemolytic Anemia in China More
More
More*
- IAVI: First Vaccinations in IAVI G004, a
Phase 1 Clinical Trial of a Promising HIV
Vaccine Approach More
- Johnson & Johnson: Submits OTTAVA
Robotic Surgical System to the U.S. Food and
Drug Administration
More
- Kallyope: 2026 Strategic Priorities for
Migraine and Metabolism Portfolio Based on
Novel Neural Circuits Platform More
- Merck: Initiates Phase 3 KANDLELIT-007 Trial
Evaluating Calderasib (MK-1084), an
Investigational Oral KRAS G12C Inhibitor, in
Combination With KEYTRUDA QLEX (pembrolizumab
and berahyaluronidase alfa-pmph) in Certain
Patients With Advanced NSCLC More
- Mezzion Pharmaceuticals: Appoints
Physician-Scientist Ridwan Shabsigh, MD,
FACS as President & Chief Operating
Officer More
- NeuraLight: Reaches Key Milestone
With Completion of International Multicenter
Parkinson’s Clinical Trial
More
- Novo Nordisk: Unveils the Inaugural State of
Weight and Health Report, Offering New
Insights That Shed Light on America’s Obesity
Epidemic More
- Outlook Therapeutics: Appoints Laura
Cantrell as Vice President of Corporate
Strategy and Business Development More
- Prokaryotics and Basilea: Enter
Collaboration to Develop a Novel
Broad-Spectrum Antifungal for Severe
Invasive Infections More
More
- Syndax and World Orphan Drug Alliance: To
Launch a Multi-Regional Managed Access
Program, Expanding Access to Revuforj
(revumenib) Outside the U.S. More
- VB Spine: Completes Acquisition of Cestas
Manufacturing Facility From Stryker More
- Volastra Therapeutics: Expands
Clinical Development Program Following
Encouraging KIF18A Inhibitor Data and
Appoints New Chief Medical Officer to Lead
Clinical Strategy More
|
|
- Bright Minds Biosciences: Launch of US$100
Million Public Offering More
- Get
Full Access to BYTE51 Life Sciences
Intelligence for 50% Off
More
- JPM Week Conference Readiness
Packages (Big4Bio Subscriber Discount) More
- Lung Cancer Research Foundation: Additional
2025 Scientific Research Grant Awards More
- Lupus Research Alliance: Launches New
Philanthropic Fund to Advance Treatments and
Diagnostics More
- Merck: To Complete Acquisition of Cidara
Therapeutics More
- More on Bright Minds’ Shares Soaring on
Positive Phase 2 Seizure Reduction Data More*
More*
More
- More on Pfizer Inking Deal to Scout
Tumour-Selective Antigens With Cartography More*
- The Reeve Foundation and Spinal Research:
Award New Grants to Advance Traumatic Spinal
Cord Injury Treatments
More
|
|
 |
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The
Big4Bio Podcast: Biotech Showcase
Readies as Biotech Stocks and Deals Pick Up
Podcast
- The Big4Bio Podcast: Every Moment
Matters: DMPK’s Role in Making Better Drugs
and Better Decisions Podcast
- Vaccine Schedule Overhaul Rankles Industry
and Tees Up Fresh Debate Over Gardasil More*
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
 |
| M&A
in Life Sciences: The Turning Tide
– Why Now is a Strategic
Inflection for Biopharma and
Biotech |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- How Industry Trends are Impacting Hiring
Decisions and Leadership Strategies in Life
Sciences More
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibilities More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
